Davis Rea LTD. raised its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 49.9% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 35,883 shares of the semiconductor company’s stock after acquiring an additional 11,940 shares during the period. Synopsys accounts for about 4.2% of Davis Rea LTD.’s investment portfolio, making the stock its 7th biggest holding. Davis Rea LTD.’s holdings in Synopsys were worth $17,704,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also made changes to their positions in the company. Alpine Bank Wealth Management grew its stake in Synopsys by 89.3% during the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock worth $26,000 after buying an additional 25 shares during the last quarter. TFC Financial Management Inc. grew its position in shares of Synopsys by 1,250.0% during the third quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock worth $27,000 after acquiring an additional 50 shares during the last quarter. Independence Bank of Kentucky increased its holdings in shares of Synopsys by 120.0% in the 2nd quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company’s stock worth $28,000 after acquiring an additional 30 shares during the period. SOA Wealth Advisors LLC. bought a new stake in Synopsys in the 3rd quarter valued at about $28,000. Finally, McIlrath & Eck LLC acquired a new position in Synopsys during the 3rd quarter valued at about $29,000. 85.47% of the stock is currently owned by institutional investors and hedge funds.
Synopsys Stock Up 0.6%
SNPS opened at $508.19 on Friday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.62. The company has a market capitalization of $97.23 billion, a PE ratio of 63.60, a P/E/G ratio of 4.21 and a beta of 1.12. The stock’s fifty day moving average is $452.89 and its 200-day moving average is $505.04. Synopsys, Inc. has a one year low of $365.74 and a one year high of $651.73.
Insider Buying and Selling
In other Synopsys news, insider Janet Lee sold 250 shares of Synopsys stock in a transaction that occurred on Monday, January 12th. The shares were sold at an average price of $530.00, for a total value of $132,500.00. Following the transaction, the insider owned 11,959 shares in the company, valued at approximately $6,338,270. The trade was a 2.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CFO Shelagh Glaser sold 3,657 shares of the stock in a transaction on Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the sale, the chief financial officer owned 17,842 shares of the company’s stock, valued at $8,221,058.34. This trade represents a 17.01% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 4,157 shares of company stock valued at $1,945,036 over the last 90 days. 0.62% of the stock is currently owned by insiders.
Analyst Ratings Changes
SNPS has been the topic of a number of recent analyst reports. BNP Paribas initiated coverage on Synopsys in a report on Thursday, October 2nd. They set an “underperform” rating and a $425.00 price target on the stock. Morgan Stanley lifted their target price on Synopsys from $510.00 to $550.00 and gave the company an “overweight” rating in a research note on Friday, December 12th. Wells Fargo & Company increased their price target on Synopsys from $445.00 to $500.00 and gave the stock an “equal weight” rating in a research note on Thursday, December 11th. Zacks Research raised Synopsys from a “strong sell” rating to a “hold” rating in a report on Monday, November 10th. Finally, Piper Sandler downgraded shares of Synopsys from an “overweight” rating to a “neutral” rating and reduced their price objective for the stock from $602.00 to $520.00 in a report on Tuesday. Nine analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $553.57.
Read Our Latest Research Report on SNPS
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- I’ve seen this pattern only twice in my 46-year career…
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Trump just signed it
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Virtually Unknown AI Company Solving Trillion-Dollar Problem
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
